Estudo de coorte | Exposição intraútero a 17-alfa-hidroxiprogesterona está associada a risco aumentado de câncer nos descendentes.

In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring – American Journal of Obstetrics and Gynecology (link para o resumo – $ para o texto completo)

Comentário: Drug used to prevent miscarriage increases risk of cancer in offspring – The University of Texas Health Science Center at Houston

Conteúdo relacionado: Randomized Trial: Injectable 17-α-hydroxyprogesterone Not Effective for the Prevention of Recurrent Preterm Birth